Medicare Enrolled

Dr. Juan Vergara Saavedra, M.D.

Internal Medicine · Tracy, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2151 W GRANT LINE RD, Tracy, CA 95377
2098320535
In practice since 2008 (17 years)
NPI: 1124295316 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vergara Saavedra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vergara Saavedra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vergara Saavedra

Dr. Juan Vergara Saavedra is an internal medicine specialist in Tracy, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Vergara Saavedra performed 2,463 Medicare services across 492 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vergara Saavedra received a total of $4,826 from 27 pharmaceutical and/or device companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vergara Saavedra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 13% volume in CA $4,826 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,463
Medicare services
Top 13% in CA for internal medicine
492
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,680 $18 $45
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
392 $90 $343
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
120 $135 $381
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
116 $63 $234
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
38 $32 $65
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
36 $75 $89
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
28 $12 $75
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
23 $106 $461
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
16 $32 $96
Pneumococcal conjugate vaccine (PCV15)
An intramuscular injection of the 15-valent pneumococcal conjugate vaccine. This vaccine protects against 15 types of pneumococcal bacteria.
14 $241 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$4,826
Total received (2018-2023)
Avg $965/year across 5 years
Top 16% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
261
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,826 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$227
2022
$354
2020
$218
2019
$1,746
2018
$2,281

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Nevro Corp.
$102
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$796
AstraZeneca Pharmaceuticals LP
$646
GlaxoSmithKline, LLC.
$632
Novo Nordisk Inc
$554
Teva Pharmaceuticals USA, Inc.
$442
PFIZER INC.
$263
Janssen Pharmaceuticals, Inc
$240
Amgen Inc.
$233
SANOFI-AVENTIS U.S. LLC
$181
Mylan Specialty L.P.
$125
Sunovion Pharmaceuticals Inc.
$125
Nevro Corp.
$102
Kowa Pharmaceuticals America, Inc.
$84
Lilly USA, LLC
$70
Takeda Pharmaceuticals U.S.A., Inc.
$53
Merck Sharp & Dohme Corporation
$48
E.R. Squibb & Sons, L.L.C.
$38
Sanofi Pasteur Inc.
$37
Genentech USA, Inc.
$24
Shire North American Group Inc
$22
ABBVIE INC.
$19
Amarin Pharma Inc.
$18
Hikma Pharmaceuticals USA
$17
Otsuka America Pharmaceutical, Inc.
$17
Ironwood Pharmaceuticals, Inc
$13
Corcept Therapeutics
$13
West-Ward Pharmaceuticals
$11
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
AJOVY · ANORO · Amitiza · BREATHTEK · BREO · CHANTIX · CINQAIR · COLOGUARD · ELIQUIS · EMBEDA · EMGALITY · EUCRISA · EVENITY · FARXIGA · GARDASIL 9 · HUMALOG · INVOKANA · JANUVIA · JARDIANCE · Korlym · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MENACTRA · Mitigare · OFEV · Ozempic · PENTACEL · PRALUENT · PREVNAR - 13 · Prolia · SHINGRIX · STIOLTO RESPIMAT · SYMBICORT · Senza · TAKHZYRO · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · UBRELVY · Vascepa · Victoza · XARELTO · Xofluza · Xultophy 100/3.6 · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Tracy?
Compare internal medicine physicians in the Tracy area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
315
Per 100K population
40.0
County median income
$88,531
Nearest hospital
SUTTER TRACY COMMUNITY HOSPITAL
6.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vergara Saavedra is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vergara Saavedra experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Vergara Saavedra performed 1,680 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vergara Saavedra receive payments from pharmaceutical companies?
Yes. Dr. Vergara Saavedra received a total of $4,826 from 27 companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vergara Saavedra's costs compare to other internal medicine physicians in Tracy?
Dr. Vergara Saavedra's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vergara Saavedra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →